CRP and peripheral arterial disease: In patients with elevated inflammatory markers [e.g., CRP, lipoprotein (a), Interleukin-6 (IL-6) and soluble intercellular adhesion molecule-1 (SICAM-1)], an increased risk for the development of PAD could impressively be shown in the Edinburgh Artery Study [8].